Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
194.4 USD | +2.03% | -1.92% | -24.88% |
19.04. | BIOGEN INC. : Needham & Co. bleibt bei seiner Kaufempfehlung | ZM |
19.04. | BIOGEN INC. : BMO Capital gibt eine Kauf-Bewertung ab | ZM |
ETFs investiert in Biogen Inc.
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
4,30% | 1 M€ | 0.00% | - | |
3,92% | 0 M€ | 0.00% | - | |
3,75% | 0 M€ | 0.00% | - | |
2,39% | 14 021 M€ | +2.68% | ||
2,28% | 4 M€ | +20.15% | ||
1,91% | 6 M€ | +16.84% | - | |
1,78% | 115 M€ | +3.12% | - | |
1,69% | 2 M€ | +5.19% | ||
1,60% | 8 M€ | -.--% | ||
1,33% | 1 182 M€ | -2.17% | ||
1,30% | 9 M€ | -4.31% | - | |
1,00% | 16 M€ | -9.75% | ||
0,99% | 18 M€ | +1.40% | - | |
0,97% | 13 M€ | -.--% | - | |
0,97% | 3 M€ | +7.32% | - | |
0,97% | 1 M€ | +11.94% | - | |
0,94% | 204 M€ | +10.54% | ||
0,65% | 2 M€ | -25.75% | ||
0,64% | 8 M€ | +5.48% | - | |
0,48% | 4 592 M€ | +11.18% | ||
0,44% | 1 M€ | +16.32% | ||
0,43% | 26 M€ | +16.85% | - | |
0,38% | 2 M€ | +20.44% | - | |
0,38% | 22 M€ | 0.00% | - | |
0,37% | 5 M€ | -72.95% | - | |
0,37% | 9 M€ | -.--% | - | |
0,36% | 3 M€ | 0.00% | - | |
0,29% | 92 M€ | +0.06% | - | |
0,29% | 469 M€ | -2.05% | - | |
0,29% | 3 859 M€ | +18.82% | - | |
0,21% | 8 M€ | +1.56% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-24.88% | 28.26 Mrd. | |
-5.99% | 83.66 Mrd. | |
+2.76% | 40.41 Mrd. | |
+53.61% | 24.53 Mrd. | |
-8.08% | 16.82 Mrd. | |
-33.74% | 13.39 Mrd. | |
-16.63% | 11.75 Mrd. | |
-11.19% | 11.69 Mrd. | |
-2.25% | 8.13 Mrd. | |
+1.05% | 7.55 Mrd. |
- Börse
- Aktien
- 789617 Aktie
- ETFs Biogen Inc.